Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 47Lung Neoplasms 23Carcinoma, Hepatocellular 23Small Cell Lung Carcinoma 16Cholangiocarcinoma 10Breast Neoplasms 10Urinary Bladder Neoplasms 9Biliary Tract Neoplasms 9Neoplasms 8Neoplasm Metastasis 8Liver Neoplasms 8Pancreatic Neoplasms 6Carcinoma 6Endometrial Neoplasms 5Triple Negative Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Transitional Cell 4Ovarian Neoplasms 3Neoplasms by Site 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Adenocarcinoma 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Respiratory Tract Neoplasms 2Pathologic Complete Response 2Oropharyngeal Neoplasms 2Neoplasms by Histologic Type 2

Interventions

durvalumab 3abemaciclib 3Fulvestrant 3Cisplatin 3ribociclib 2pembrolizumab 2palbociclib 2Pemetrexed 2Nivolumab 2Letrozole 2Carboplatin 2Bevacizumab 2Anastrozole 2130-nm albumin-bound paclitaxel 2selpercatinib 1selinexor 1repotrectinib 1relatlimab 1relacorilant 1olaparib 1gallium 68 PSMA-11 1exemestane 1enfortumab vedotin 1elacestrant 1darolutamide 1cemiplimab 1atezolizumab 1Tamoxifen 1Sunitinib 1STX-478 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms by Site × durvalumab × 90 days × Clear all
NCT06463665 2026-06-04

VIRO-25

Genelux Corporation

Phase 2 Recruiting
142 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

NCT05063565 2026-06-01

ROWAN

Boston Scientific Corporation

Phase 2 Active not recruiting
100 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT06606847 2026-05-15

LADOGA

AstraZeneca

Phase 2 Active not recruiting
30 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡